Abstract
A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 404-407 |
| Number of pages | 4 |
| Journal | Journal of Neurology Neurosurgery and Psychiatry |
| Volume | 41 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1978 |
| Externally published | Yes |
ASJC Scopus subject areas
- Surgery
- Clinical Neurology
- Psychiatry and Mental health